Efficacy and safety of vedolizumab in elderly patients with inflammatory bowel disease: a matched case–control study

BACKGROUND: Vedolizumab was demonstrated to be safe and effective in adults with moderately to severely active inflammatory bowel disease (IBD) in clinical trials. However, there are limited data regarding its efficacy and safety in elderly patients. METHODS: This was a case–control study comparing...

Descripción completa

Detalles Bibliográficos
Autores principales: Shashi, Preeti, Gopalakrishnan, Dharmesh, Parikh, Malav P, Shen, Bo, Kochhar, Gursimran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434586/
https://www.ncbi.nlm.nih.gov/pubmed/32843978
http://dx.doi.org/10.1093/gastro/goz041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434586/
https://www.ncbi.nlm.nih.gov/pubmed/32843978
http://dx.doi.org/10.1093/gastro/goz041

Ejemplares similares